ਗਾਲਬਲੈਡਰ ਕੈਂਸਰ

Evidence suggests distinct models of molecular and pathologic progression, and a growing body of genetics data points to a heterogeneous collection of underlying mutations in key oncogenes and tumor suppressor genes. Although tumor genetics have been used to tailor individual treatment regimens and guide clinical decision making in other cancers, these principles have not been applied in gallbladder malignancy. Recent clinical trials with targeted therapies seem promising, although the relationships between subsets of patients with positive responses to therapy and tumor genetics remain unexpl…

ਸਪਾન્સર: Banaras Hindu University
NCT05404347 on ClinicalTrials.gov
ਰਜਿਸਟਰੀ ਵਿੱਚ ਆਖਰੀ ਵਾਰ 13 Aug 2024 ਨੂੰ ਅਪਡੇਟ ਕੀਤਾ ਗਿਆ · ਅਸੀਂ 20 Oct 2026 ਨੂੰ ਪੜ੍ਹਿਆ